Gilead Sciences, Inc. announced its financial results for the quarter ending September 30, 2025, on October 30, 2025, detailing both GAAP and non-GAAP metrics to aid investor understanding. This filing is deemed significant and has a neutral sentiment from an equity investor perspective.